OXON Epidemiology to Exhibit at the ISPE Annual Meeting 2026
29 August – 2 September 2026 | Allianz MiCo Convention Centre | Milan, Italy
As an international contract research organisation (CRO) specialising in Real-World Evidence, pharmacoepidemiology and late-phase research, OXON Epidemiology is pleased to announce its participation as an exhibitor at the 42nd International Society for Pharmacoepidemiology (ISPE) Annual Meeting, taking place in Milan from 29 August to 2 September 2026.
As one of the leading international meetings dedicated to Pharmacoepidemiology and Real-World Evidence (RWE), the ISPE Annual Meeting provides an excellent opportunity to visit OXON at Booth 206 and discover how we transform real-world data into reliable evidence through scientifically robust methodologies, operational excellence and global expertise.
From Real-World Data to Reliable Evidence – Visit Booth 206
At OXON, our mission is simple: transforming real-world data into reliable evidence.
Our capabilities include observational studies, patient registries, PASS and PAES, drug utilisation studies, safety and effectiveness research, primary and secondary data collection, and global project management. Every project is tailored to the specific scientific and operational needs of our clients, ensuring high-quality data and reliable outcomes. Whether you are planning a multinational study, exploring new evidence generation strategies or looking for an experienced partner to support complex international programmes, we invite you to visit Booth 206, where our scientific, epidemiology and business development teams will be available throughout the meeting.
We look forward to discussing your research objectives, sharing examples of our work and exploring opportunities for future collaboration.
OXON Scientific Contributions at ISPE 2026
In addition to exhibiting, OXON researchers have co-authored two scientific posters that have been accepted for presentation during this year’s meeting.
These presentations reflect OXON’s ongoing commitment to advancing pharmacoepidemiological research and contributing to the development of innovative methodologies and high-quality Real-World Evidence.
- B-077 – Malignancy rates in patients with Crohn’s disease with and without perianal fistula: A French retrospective cohort study Poster Session B – Tuesday, 1 September 2026 – 11:30 AM – 1:00 PM CEST
- C-340 – Applying an Estimand Framework to Observational Hypertension Research: A Case Study on Handling Intercurrent Events Poster Session C -Wednesday, 2 September 2026 – 12:00 PM – 1:30 PM CEST
If you are attending the ISPE Annual Meeting 2026 and would like to arrange a meeting with our team, we would be delighted to hear from you. Contact us in advance or visit Booth 206 during the meeting.
